Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
T. Rowe Price Associates Inc reported a 5.10% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
T. Rowe Price Associates Inc reported a 5.10% stake in Crinetics Pharmaceuticals, Inc., 5,355,011 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 5,355,011
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 5.10% | 5,355,011 |